Call Options

23 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$10.66 - $17.48 $1.48 Million - $2.43 Million
-139,100 Reduced 81.68%
31,200 $505,000
Q2 2024

Aug 15, 2024

SELL
$10.45 - $13.76 $497,419 - $654,976
-47,600 Reduced 21.84%
170,300 $1.85 Million
Q1 2024

May 07, 2024

BUY
$9.99 - $14.91 $1.29 Million - $1.93 Million
129,300 Added 145.94%
217,900 $3.05 Million
Q4 2023

Feb 14, 2024

BUY
$7.6 - $10.53 $68,400 - $94,770
9,000 Added 11.31%
88,600 $932,000
Q3 2023

Nov 14, 2023

BUY
$7.15 - $10.2 $296,010 - $422,279
41,400 Added 108.38%
79,600 $727,000
Q2 2023

Aug 11, 2023

BUY
$7.23 - $10.52 $174,966 - $254,584
24,200 Added 172.86%
38,200 $277,000
Q1 2023

May 16, 2023

SELL
$7.81 - $11.05 $400,653 - $566,865
-51,300 Reduced 78.56%
14,000 $118,000
Q4 2022

Feb 14, 2023

SELL
$6.52 - $8.95 $200,816 - $275,660
-30,800 Reduced 32.05%
65,300 $490,000
Q3 2022

Nov 14, 2022

SELL
$7.76 - $13.72 $239,008 - $422,576
-30,800 Reduced 24.27%
96,100 $774,000
Q2 2022

Aug 15, 2022

SELL
$10.22 - $13.94 $680,652 - $928,404
-66,600 Reduced 34.42%
126,900 $1.47 Million
Q1 2022

May 16, 2022

BUY
$5.22 - $11.78 $641,016 - $1.45 Million
122,800 Added 173.69%
193,500 $2.17 Million
Q4 2021

Feb 14, 2022

SELL
$5.37 - $8.38 $96,660 - $150,840
-18,000 Reduced 20.29%
70,700 $460,000
Q3 2021

Nov 15, 2021

SELL
$7.36 - $13.67 $629,280 - $1.17 Million
-85,500 Reduced 49.08%
88,700 $676,000
Q2 2021

Aug 11, 2021

SELL
$8.42 - $13.96 $1.04 Million - $1.72 Million
-123,400 Reduced 41.47%
174,200 $2.2 Million
Q1 2021

May 17, 2021

BUY
$3.2 - $16.51 $839,360 - $4.33 Million
262,300 Added 743.06%
297,600 $3.87 Million
Q4 2020

Feb 16, 2021

SELL
$2.92 - $4.84 $299,884 - $497,068
-102,700 Reduced 74.42%
35,300 $119,000
Q3 2020

Nov 16, 2020

SELL
$3.03 - $5.48 $18,483 - $33,428
-6,100 Reduced 4.23%
138,000 $540,000
Q2 2020

Aug 14, 2020

BUY
$3.53 - $6.17 $450,075 - $786,675
127,500 Added 768.07%
144,100 $764,000
Q1 2020

May 15, 2020

SELL
$3.53 - $12.21 $143,318 - $495,726
-40,600 Reduced 70.98%
16,600 $69,000
Q4 2019

Feb 14, 2020

SELL
$11.58 - $17.37 $859,236 - $1.29 Million
-74,200 Reduced 56.47%
57,200 $696,000
Q3 2019

Nov 14, 2019

BUY
$13.91 - $19.87 $516,061 - $737,177
37,100 Added 39.34%
131,400 $2.05 Million
Q2 2019

Aug 14, 2019

SELL
$13.19 - $28.36 $291,499 - $626,756
-22,100 Reduced 18.99%
94,300 $1.38 Million
Q1 2019

May 15, 2019

BUY
$12.43 - $28.91 $1.45 Million - $3.37 Million
116,400 New
116,400 $2.63 Million

Others Institutions Holding EOLS

About Evolus, Inc.


  • Ticker EOLS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 56,094,800
  • Market Cap $609M
  • Description
  • Evolus, Inc., a performance beauty company, provides medical aesthetic products for physicians and their patients in the United States. It offers Jeuveau, a proprietary 900 kilodalton purified botulinum toxin type A formulation for the temporary improvement in the appearance of moderate to severe glabellar lines in adults. The company was incorp...
More about EOLS
Track This Portfolio

Track Susquehanna International Group, LLP Portfolio

Follow Susquehanna International Group, LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna International Group, LLP with notifications on news.